Join us with our guest:

Candida Fratazzi, MD, Consulting Medical Director at Vedanta Biosciences, focused on pioneering rational design of drugs, made of defined consortia of bacteria, to Modulate the Human Microbiome.

Dr. Fratazzi will be discussing and explaining Microbiome functions and how its changes impact our health. How bacteria colonies’ equilibrium is supported and supports our immune system. Thus, the need to correct imbalance of bacteria colonies not with untargeted pull of bacteria such as fecal transplant or with a single strain of bacteria such as probiotics. Dr Fratazzi will certainly be educating us on this episode, Why Bacterial Consortia May Stop C. diff. Recurrences”

Join us with Guest; Doe Kley, RN, CIC, MPH,T-CHEST

Senior Infection Preventionist with

Clorox Professional Products Co.

Ms. Kley will be discussing the importance of knowing the key-points in transitioning from an acute-care facility, long-term facility, and intermediate healthcare facility to the home environment.

Join us with Guest; Doe Kley, RN, CIC, MPH,T-CHEST

Senior Infection Preventionist with

Clorox Professional Products Co.

Ms. Kley will be discussing the importance of knowing the key-points in transitioning from an acute-care facility, long-term facility, and intermediate healthcare facility to the home environment.

Join us with our Guest;

Dale N. Gerding, MD, MACP, FIDSA, FSHEA. Dr. Gerding is a Research Physician at the Edward Hines Jr. VA Hospital and Professor of Medicine at Loyola University Chicago Stritch School of Medicine in Maywood, Illinois (retired). Dr. Gerding's

long and distinguished career includes past president of the Society for Healthcare Epidemiology of America, past chair of the antibiotic resistance committee of SHEA and past chair of the National and Global Public Health Committee and the Antibiotic Resistance Subcommittee of IDSA. He was the recipient of the 2013 William S. Middleton Award. The Middleton Award is the highest honor awarded annually by the Biomedical Laboratory Research and Development Service to senior VA biomedical research scientists.

Dr. Gerding will be discussing C. diff. as a bacterium, the infection on the Epidemiology level in prevention, treatments, with the research and development of Clinical Trials. This super bug history is a stellar beginning

Join us with our guest: Ms. Courtney Jones, Upstream Marketing Manager and Senior Project Manager at Rebiotix, a Ferring Pharmaceuticals company, focused on harnessing the power of the human microbiome to treat debilitating diseases.

Ms. Jones will be discussing and explaining the Microbiome. What Microbes are and the difference between the good, bad, and in between and what the Microbiome has to do with C.diff. treatment.

There is a lot to learn about the science of the Microbiome and Ms. Jones will certainly be educating us on this episode, Researching Bugs as Drugs to Fight C.diff..

Our two guests, Teena Chopra, MD, MPH and Glenn Tillitson, PhD,FIDSA, will be discussing how C. diff. infections correlate with COVID-19 and how the pandemic not only provides lessons about the judicious use of antibiotics, but it also highlights another global health threat that has been playing out in slow motion: the mounting threat of antimicrobial resistance that annually claims 700,000 lives as the world’s arsenal of antibiotics and antifungal medication lose their ability to vanquish dangerous pathogens.

There will be discussions focused on studies, and what may be the epidemiological impact of COVID/CDI in post hospital care and much more.

Our two guests, Teena Chopra, MD, MPH and Glenn Tillitson, PhD,FIDSA, will be discussing how C. diff. infections correlate with COVID-19 and how the pandemic not only provides lessons about the judicious use of antibiotics, but it also highlights another global health threat that has been playing out in slow motion: the mounting threat of antimicrobial resistance that annually claims 700,000 lives as the world’s arsenal of antibiotics and antifungal medication lose their ability to vanquish dangerous pathogens.

There will be discussions focused on studies, and what may be the epidemiological impact of COVID/CDI in post hospital care and much more.

Join us in Part II of this educational discussion with guests Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC and Denise Graham discussing a safe, continuous, green, and real-time technology. Learn how a room’s ambient humidity and oxygen naturally present in the environment can significantly reduce the levels of environmental bio-burden in the air and on surfaces while working in occupied spaces.The use of the Synexis technology is similar to providing an immune system for a building. Evidence-based microbial reductions and research will be shared.

Join us with guests Maureen Spencer, M.Ed, BSN, RN, CIC, FAPIC and Denise Graham in discussing a safe, continuous, green, and real-time technology. Learn how a room’s ambient humidity and oxygen naturally present in the environment can significantly reduce the levels of environmental bio-burden in the air and on surfaces while working in occupied spaces.The use of the Synexis technology is similar to providing an immune system for a building. Evidence-based microbial reductions will be shared.

Join us with our Host, Nancy Caralla and our special Guest Host, Kevin Hersh, International Health Coach who will discuss ways to move forward past a long-term illness, and a long-term negative mind-set. Taking a moment to reflect, step back, evaluate, and look for the assets and positives in moving forward. Learn how to let the past go and embrace the new opportunities each day delivers. It takes strength, will, and the determination to step into the light and out of the darkness of the illness that paralyzes a healthy individual. Join us and take a step in a new direction.